1. Kramer L, Jordan B, Druml W et al (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med 35:1099–1104. https://doi.org/10.1097/01.ccm.0000259462.97164.a0
2. Fuhrmann V, Kneidinger N, Herkner H et al (2011) Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37:1302–1310. https://doi.org/10.1007/s00134-011-2248-7
3. Berg TNFA, Bruns T, Martin-Walter W, Weismüller T, Jonel T, Tacke F, Strnad P, Sterneck M, Settmacher U, Seehofer D, Schott E, Schnitzbauer AA, Schmidt HH, Schlitt HJ, Pratschke J, Pascher A, Neumann U, Manekeller S, Lammert F, Klein I, Kirchner G, Guba M, Glanemann M, Engelmann C, Canbay AE, Braun F, Berg C, Bechstein WO, Becker T, Trautwein C (2023ed) S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), 2023. Aufl.
4. Lee WM, Stravitz RT, Larson AM (2012) Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 55:965–967. https://doi.org/10.1002/hep.25551
5. Wendon J, Cordoba J, Dhawan A et al (2017) EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 66:1047–1081. https://doi.org/10.1016/j.jhep.2016.12.003